A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer
Clinical trial NCT02443467 · COMPLETED
Trial details
- NCT number
- NCT02443467
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-11-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.